Invokana (canagliflozin)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Acute Kidney Injury and Impairment in Renal Function
INVOKANA causes intravascular volume...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts